Long-term follow-up for multidrug-resistant tuberculosis.
Patients treated in Peru for multidrug-resistant tuberculosis (MDR-TB) were followed-up for a median of 67 months. Among 86 patients considered cured after completion of treatment, 97% remain healthy; 1 patient relapsed. Employment increased from 34% before treatment to 71%. We observed favorable long-term outcomes among MDR-TB patients.
Shin
Sonya S
SS
Brigham and Women's Hospital, Boston, Massachusetts, USA.
Furin
Jennifer J
JJ
Alcántara
Felix
F
Bayona
Jaime
J
Sánchez
Epifanio
E
Mitnick
Carole D
CD
D000995:Antitubercular Agents; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D010568:Peru / Q000453:epidemiology; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D014376:Tuberculosis / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology*
D000995:Antitubercular Agents